Showing results (161-170 of 252) with videos related to
Sort By:
Pageof 26
Journal of the American Chemical Society|April 14, 2005
Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interactionHang Yin, Gui-In Lee, Kristine A Sedey, et al.Drug Development Research|May 15, 2025
Augmenting the Anti-Leukemic Activity of the BCL-2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL-2/HDAC1 and Dual BCL-2/HDAC6 InhibitorsAlexandria M Chan, Christian Eberly, Brandon Drennen, et al.The Laryngoscope|May 21, 2013
The effect of geniglossal advancement on airway flow using a computational flow dynamics modelAaron Fletcher, Jiwoong Choi, Maged Awadalla, et al.Chemmedchem|July 1, 2014
Discovery of methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate, an improved small-molecule inhibitor of c-Myc-max dimerizationJay Chauhan, Huabo Wang, Jeremy L Yap, et al.Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|June 23, 2025
What Factors Influence Success of Mandibular Reconstructions With Patient-Specific Selective Laser Melted Reconstruction Plates?Jeffrey S Marschall, Mitchell Frerichs, Thomas Keith, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosisClaire E Walters, Gareth Pryce, Deborah J R Hankey, et al.Communications Biology|November 6, 2025
O-glycosylated peptides curtail the aggregation and toxicity of human islet amyloid polypeptideQian Zhang, Xiaohan Mei, Yan Li, et al.Angewandte Chemie (International Ed. in English)|February 21, 2014
Diphenylacetylene-linked peptide strands induce bidirectional β-sheet formationHannah Lingard, Jeongmin T Han, Amber L Thompson, et al.European Journal of Medicinal Chemistry|January 15, 2025
The polypharmacy combination of the BCL-2 inhibitor venetoclax (VEN) and the FLT3 inhibitor gilteritinib (GIL) is more active in acute myeloid leukemia cells than novel polypharmacologic BCL-2/FLT3 VEN-GIL hybrid single-molecule inhibitorsChristopher C Goodis, Christian Eberly, Alexandria M Chan, et al.Drug Design, Development and Therapy|February 28, 2020
Optimization of a Benzothiazole Indolene Scaffold Targeting Bacterial Cell Wall AssemblyJay Chauhan, Wenbo Yu, Steven Cardinale, et al.Pageof 26